UNIVERSAL OMICS

Artificial intelligence has ushered in a new era of innovation in biotechnology and in the way therapies and drugs are developed. Matxalen Uriarte, PhD in Biochemistry, is passionate about deep learning technologies to apply to data and bioscientific knowledge. This has led her to seek allies and found Universal OMICS, a company that has developed software capable of calculating the efficacy of drugs, nutraceuticals and molecules for non-communicable diseases, such as cardiac disease.